Literature DB >> 12650884

What happens when cardiac Na channel function is compromised? 2. Numerical studies of the vulnerable period in tissue altered by drugs.

C Frank Starmer1, A O Grant, T J Colatsky.   

Abstract

OBJECTIVE: The fate of an impulse arising from stimulation is determined by the ability of the wave front to recruit sufficient Na channels from adjacent cells. Previous numerical studies of mutant Na channels revealed both the velocity of a conditioning wave and the recruiting capacity of the front as determinants of the vulnerable period (VP), an interval within which excitation results in unidirectional conduction. Drugs that block excitatory Na channels in a voltage dependent manner, such as antiarrhythmics, abused substances and antidepressants, slow the restoration of Na conductance trailing an action potential and are associated with proarrhythmia and sudden cardiac death. We hypothesized that drug-induced slowing of Na conductance recovery would flatten the Na conductance restoration gradient thereby reducing the recruiting capacity of a front, extending the VP and increasing the probability of unidirectional propagation.
METHODS: In a cable of ventricular cells, we explored the sensitivity of the VP to voltage-dependent blockade. While varying the unbinding time constant from 100 ms to 5 s, we measured the Na conductance restoration gradient, the liminal length, the refractory period (RP) and the VP.
RESULTS: Reducing the rate of drug unbinding flattened the restoration gradient, diminished the recruiting capacity of a premature impulse and extended the liminal length, RP and the VP. The VP was linearly dependent on the drug unbinding time constant. Rapidly unbinding drugs (time constant <1 s) reduced the liminal length below that of a quiescent cable.
CONCLUSIONS: Slowing the unbinding rate of voltage-dependent drug block of Na channels extended the RP and the VP. Drugs with unbinding time constants greater than 1 s dramatically increased the probability of unidirectional propagation, reflecting increases in both the RP and the VP. This study provides a new mechanism linking Na channel function, compromised by voltage-dependent Na channel drug block, with proarrhythmic conditions that can lead to sudden cardiac death following premature stimulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12650884     DOI: 10.1016/s0008-6363(02)00727-7

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  7 in total

1.  In silico optimization of atrial fibrillation-selective sodium channel blocker pharmacodynamics.

Authors:  Martin Aguilar-Shardonofsky; Edward J Vigmond; Stanley Nattel; Philippe Comtois
Journal:  Biophys J       Date:  2012-03-06       Impact factor: 4.033

2.  New aspects of vulnerability in heterogeneous models of ventricular wall and its modulation by loss of cardiac sodium channel function.

Authors:  A Kapela; N Tsoukias; A Bezerianos
Journal:  Med Biol Eng Comput       Date:  2005-05       Impact factor: 2.602

3.  Cardiac Safety Implications of hNav1.5 Blockade and a Framework for Pre-Clinical Evaluation.

Authors:  Gül Erdemli; Albert M Kim; Haisong Ju; Clayton Springer; Robert C Penland; Peter K Hoffmann
Journal:  Front Pharmacol       Date:  2012-01-26       Impact factor: 5.810

Review 4.  The virtual heart as a platform for screening drug cardiotoxicity.

Authors:  Yongfeng Yuan; Xiangyun Bai; Cunjin Luo; Kuanquan Wang; Henggui Zhang
Journal:  Br J Pharmacol       Date:  2015-01-13       Impact factor: 8.739

5.  KChIP2 is a core transcriptional regulator of cardiac excitability.

Authors:  Drew M Nassal; Xiaoping Wan; Haiyan Liu; Danielle Maleski; Angelina Ramirez-Navarro; Christine S Moravec; Eckhard Ficker; Kenneth R Laurita; Isabelle Deschênes
Journal:  Elife       Date:  2017-03-06       Impact factor: 8.140

Review 6.  Computational Modeling of Electrophysiology and Pharmacotherapy of Atrial Fibrillation: Recent Advances and Future Challenges.

Authors:  Márcia Vagos; Ilsbeth G M van Herck; Joakim Sundnes; Hermenegild J Arevalo; Andrew G Edwards; Jussi T Koivumäki
Journal:  Front Physiol       Date:  2018-09-04       Impact factor: 4.566

7.  The K219T-Lamin mutation induces conduction defects through epigenetic inhibition of SCN5A in human cardiac laminopathy.

Authors:  Nicolò Salvarani; Silvia Crasto; Michele Miragoli; Alessandro Bertero; Marianna Paulis; Paolo Kunderfranco; Simone Serio; Alberto Forni; Carla Lucarelli; Matteo Dal Ferro; Veronica Larcher; Gianfranco Sinagra; Paolo Vezzoni; Charles E Murry; Giuseppe Faggian; Gianluigi Condorelli; Elisa Di Pasquale
Journal:  Nat Commun       Date:  2019-05-22       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.